Federal enforcement against CBD medical claims in the US is going strong, with the Federal Trade Commission (FTC) recently sending a warning letter to a new company about what it said were prohibited medical claims
Get 7 days of access to industry updates through our news analysis and regulatory alerts
"*" indicates required fields